Here is What Hedge Funds Think About Insmed Incorporated (INSM)

As aggregate interest increased, some big names were breaking ground themselves. PEAK6 Capital Management, managed by Matthew Hulsizer, created the largest call position in Insmed Incorporated (NASDAQ:INSM), worth and estimated $0.4 million at the end of the quarter. Paul Tudor Jones’s Tudor Investment Corp also made a $0.3 million investment in the stock during the quarter. The only other fund with a brand new INSM position is Chao Ku’s Nine Chapters Capital Management.

Let’s now review hedge fund activity in other stocks similar to Insmed Incorporated (NASDAQ:INSM). These stocks are Eagle Pharmaceuticals Inc (NASDAQ:EGRX), Federal-Mogul Corporation (NASDAQ:FDML), Seres Therapeutics Inc (NASDAQ:MCRB), and NuStar GP Holdings, LLC (NYSE:NSH). This group of stocks’ market values resemble INSM’s market value.

As you can see these stocks had an average of 12 hedge funds with bullish positions and the average amount invested in these stocks was $327 million. That figure was $247 million in INSM’s case. Eagle Pharmaceuticals Inc (NASDAQ:EGRX) is the most popular stock in this table. On the other hand NuStar GP Holdings, LLC (NYSE:NSH) is the least popular one with only 9 bullish hedge fund positions. With 17 elite hedge funds among its shareholder, Insmed Incorporated (NASDAQ:INSM) is clearly the crowd’s favorite. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.